PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
11746366-3	2001	L-Aspartate, L-glutamate and L-cysteate produced an equivalent degree of [3H] exchange to that observed with D-aspartate, although the non-substrate EAAT2 inhibitor dihydrokainate and D-glutamate, which does not interact with the substrate binding site, failed to stimulate [3H]D-aspartate exchange.	L-Cysteic acid	29-39	solute carrier family 1 member 2	Homo sapiens	149-154
12649361-3	2003	We discovered that L-homocysteine sulfinic acid (L-HCSA), L-homocysteic acid, L-cysteine sulfinic acid, and L-cysteic acid are potent and effective agonists at several rat metabotropic glutamate receptors (mGluRs).	L-Cysteic acid	108-122	glutamyl-tRNA synthetase 2, mitochondrial	Mus musculus	206-212
19923702-4	2009	CAM contains bi-layers of L-cysteic acid molecules separated by water molecules which form donor interactions to the bi-layers above and below.	L-Cysteic acid	26-40	calmodulin 3	Homo sapiens	0-3
34068845-6	2021	We determined the kinetic constants using L-cysteine sulfinic acid as substrate, and also showed that human cysteine sulfinic acid decarboxylase is capable to catalyze the decarboxylation-besides its natural substrates L-cysteine sulfinic acid and L-cysteic acid-of L-aspartate and L-glutamate, although with much lower efficiency.	L-Cysteic acid	248-262	cysteine sulfinic acid decarboxylase	Homo sapiens	108-144
34664263-27	2021	The pooled results for the exploratory outcome, the rate of exacerbations requiring oral corticosteroids (OCS) or hospitalisation or emergency department visit, may be lower in participants receiving anti-interleukin-13/-4 agents versus placebo (rate ratio 0.71, 95% CI 0.65 to 0.77; low-certainty evidence).	L-Cysteic acid	106-109	interleukin 13	Homo sapiens	205-219
34959433-4	2021	The mucin adsorption of Cur-NSs was steeply increased about 3-4 times by CS and OCS coating.	L-Cysteic acid	80-83	LOC100508689	Homo sapiens	4-9
35487369-1	2022	BACKGROUND: Reslizumab, a biologic targeting interleukin-5 has been shown to reduce asthma exacerbations and maintenance oral corticosteroid (OCS) use in randomized controlled trials and pre-post studies in patients with severe eosinophilic asthma.	L-Cysteic acid	142-145	interleukin 5	Homo sapiens	45-58
35618669-10	2022	Therefore, OCS is a safe and effective technique to enlarge the cardiac donor pool in both DBD and DCD, with additional benefits for long-distance transport and surgically complex procedures.	L-Cysteic acid	11-14	dermcidin	Homo sapiens	99-102
35574049-4	2023	In this study, a regenerative scaffold regulating the macrophage immune microenvironment and promoting bone regeneration in a dual-stage process for the postoperative treatment of bone tumors was constructed by binding a colony-stimulating factor 1 receptor (CSF-1R) inhibitor GW2580 onto in situ cosslinked hydroxybutylchitosan (HBC)/oxidized chondroitin sulfate (OCS) hydrogel layer covering a 3D printed calcium phosphate scaffold based on electrostatic interaction.	L-Cysteic acid	365-368	colony stimulating factor 1 receptor	Homo sapiens	221-257
35574049-4	2023	In this study, a regenerative scaffold regulating the macrophage immune microenvironment and promoting bone regeneration in a dual-stage process for the postoperative treatment of bone tumors was constructed by binding a colony-stimulating factor 1 receptor (CSF-1R) inhibitor GW2580 onto in situ cosslinked hydroxybutylchitosan (HBC)/oxidized chondroitin sulfate (OCS) hydrogel layer covering a 3D printed calcium phosphate scaffold based on electrostatic interaction.	L-Cysteic acid	365-368	colony stimulating factor 1 receptor	Homo sapiens	259-265
33314542-10	2021	CONCLUSIONS: We established patient need for a decision aid on OCS use during pregnancy that providers can discuss with patients.	L-Cysteic acid	63-66	activation induced cytidine deaminase	Homo sapiens	56-59
6955797-3	1982	Intensification of CSADCase immunoreactivity was achieved by pretreatment of the animal with L-cysteine or L-cysteic acid intravenously 1-2 hr prior to perfusion.	L-Cysteic acid	107-121	cysteine sulfinic acid decarboxylase	Rattus norvegicus	19-27
6955797-4	1982	A combination of L-cysteic acid and demecolcine, which retards axoplasmic flow, was most effective in maximizing CSADCase immunoreactivity.	L-Cysteic acid	17-31	cysteine sulfinic acid decarboxylase	Rattus norvegicus	113-121
35288647-8	2022	Notably, only the U-ATX levels inversely fluctuated depending on the status of disease activity whether OCS had been used or not.	L-Cysteic acid	104-107	ectonucleotide pyrophosphatase/phosphodiesterase 2	Homo sapiens	20-23
33221959-10	2021	The increase in IL-6 level induced by OCS was maintained for 24 h. The OCS also increased the number of white blood cells and the percentage of neutrophils in BALFs.	L-Cysteic acid	38-41	interleukin 6	Mus musculus	16-20
33413387-6	2021	In multivariate analyses, sputum ACE2 levels were positively associated with OCS use and male gender.	L-Cysteic acid	77-80	angiotensin converting enzyme 2	Homo sapiens	33-37
33421388-7	2021	Median operation time during HTx in the OCS group was 616 (270- 809) min vs. 329 (283- 617) min.	L-Cysteic acid	40-43	Zic family member 3	Homo sapiens	29-32
32937821-7	2020	In addition to direct impact on OCs and OBs, the activity of NRF2 on myeloma cells and mesenchymal stromal cells influences the inflammatory stress/ROS level in these cells, which has an impact on OCs, OBs, and osteocytes.	L-Cysteic acid	32-35	NFE2 like bZIP transcription factor 2	Homo sapiens	61-65
31933103-9	2020	We also compared the effects of several OCs that are oxidized at the carbon-6 and -7 in the B-ring of cholesterol on FASN gene promoter activities.	L-Cysteic acid	40-43	fatty acid synthase	Homo sapiens	117-121
30940770-2	2019	High-dose OCS reduced median blood eosinophils (-60 cells/microl; 95% CI -140 to 10), periostin (-8.4 ng/mL; -11.6 to -2.8), FeNO (-19.0 ppb; -28.5 to -4.0), IL-5 (-0.17 pg/mL; -0.28 to -0.08) and IL-13 (-0.15 pg/mL; -0.27 to -0.03).	L-Cysteic acid	10-13	periostin	Homo sapiens	86-95
30940770-2	2019	High-dose OCS reduced median blood eosinophils (-60 cells/microl; 95% CI -140 to 10), periostin (-8.4 ng/mL; -11.6 to -2.8), FeNO (-19.0 ppb; -28.5 to -4.0), IL-5 (-0.17 pg/mL; -0.28 to -0.08) and IL-13 (-0.15 pg/mL; -0.27 to -0.03).	L-Cysteic acid	10-13	interleukin 5	Homo sapiens	158-162
30940770-2	2019	High-dose OCS reduced median blood eosinophils (-60 cells/microl; 95% CI -140 to 10), periostin (-8.4 ng/mL; -11.6 to -2.8), FeNO (-19.0 ppb; -28.5 to -4.0), IL-5 (-0.17 pg/mL; -0.28 to -0.08) and IL-13 (-0.15 pg/mL; -0.27 to -0.03).	L-Cysteic acid	10-13	interleukin 13	Homo sapiens	197-202
29849682-4	2017	The level of serum IL-8 was compared between the glucocorticosteroid groups, receiving inhaled corticosteroids (ICs), oral corticosteroids (OCs), and intravenous corticosteroids (GCs), respectively.	L-Cysteic acid	140-143	C-X-C motif chemokine ligand 8	Homo sapiens	19-23
24754754-2	2014	The water-mediated neutral hydrolysis mechanism of carbonyl sulfide (OCS) has been re-examined using the hybrid supramolecule/continuum models with n = 2-8 explicit water cluster at the level of MP2(fc)(CPCM)/6-311++G(d,p)//MP2(fc)(CPCM)/6-31+G(d).	L-Cysteic acid	69-72	tryptase pseudogene 1	Homo sapiens	195-198
24754754-2	2014	The water-mediated neutral hydrolysis mechanism of carbonyl sulfide (OCS) has been re-examined using the hybrid supramolecule/continuum models with n = 2-8 explicit water cluster at the level of MP2(fc)(CPCM)/6-311++G(d,p)//MP2(fc)(CPCM)/6-31+G(d).	L-Cysteic acid	69-72	tryptase pseudogene 1	Homo sapiens	224-227
31603626-3	2019	In our study, astilbin was found to have an inhibitory effect on the RANKL-induced formation and function of OCs in a dose-dependent manner without cytotoxicity.	L-Cysteic acid	109-112	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	69-74